Rightangled, London, a genetic testing company that was seed funded in 2017 by NHS England, is now entering the US market with its genetic testing service and Cloud-based platform that specialists and consumers can access to empower tailored health and fitness action plans.
Rightangled’s online platform is uniting medical and health experts to deliver rapid analysis of patients’ DNA in a bid to reduce costs and improve lives. Registered with the UK’s Care Quality Commission, Rightangled is gaining attention in both the UK and the United States for its ability to combine testing of thousands of genetic markers with a specialist review of that data. When combined with users’ environmental factors (age, weight, diet, lifestyle, etc.), the genetic information is helping health and fitness professionals advise treatments, diet, and exercise plans that exactly match users’ unique profiles.
Rightangled recently announced that it will be joining the Association of British Healthtech Industries (ABHI) innovation hub, a unique partnership between ABHI and the Dell Medical School at the University of Texas, Austin.
Abdullah Sabyah, Rightangeled.
“Genetic information is the language of life. Its insight gives doctors and fitness professionals a more precise and accurate outlook,” says Abdullah Sabyah, cofounder and CEO of Rightangled. “Knowing this information helps take the guesswork out of prescribing treatments, constructing diet and fitness programs, and then figuring out how successful they ultimately become.
“Interestingly, we are seeing more and more doctors using genetic information nowadays,” adds Sabyah “Our mission is to enable genetic analysis to become a regular activity inside medical practices, fitness and wellness centers in the UK, and further in the United States as well. The aim is to help specialists deliver the right care to their clients by giving them an instruction manual for that unique individual.”
Recognized by leading private medical insurance companies, Rightangled has sought to create a platform that automates the process of testing, generating reports, and connecting specialists with users online. The process enables practitioners to conduct their analyses remotely and provide action plans that users can then follow to optimize their health and minimize their risks.
“We have invested in Rightangled because its technology and service offerings align with our work for the NHS, supporting the establishment of a regional genomics medicine service that takes in all aspects of personalized medicine and prevention—as well as effective diagnosis,” says Tony Davis, commercial director for the NHS West Midlands Academic Health Science Network.
“The ABHI innovation hub at the Dell Medical School will offer Rightangled a unique opportunity to collaborate in a truly world-class facility,” says Philip Kennedy, chair of ABHI. “The hub will support promising health technology innovation whilst looking to develop value-based healthcare for the benefit of patients in Texas, throughout the United States, and at home in the UK.”
“When we released our initial product, theHeart DNA test, our first online order came from the United States,” says Sabyah. “For us, that was a sign, and now the United States is 20% of our monthly sales. This organic US growth has been taking place without a marketing campaign or local business development.”
Rightangled has now opened an office at the Dell Medical School and has begun signing service agreements with regional healthcare providers in Texas, partnering with logistics suppliers, accredited labs, and other partners in the United States with whom they will be delivering their services to the American consumer.
For further information, visit Rightangled.
Featured image: Genetic test kits from Rightangled.
